Clinical Trials in Philadelphia

Showing 8481-8500 of 20,904 trials

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

NCT03970200

This is a randomized, open label, comparative, Phase II study to determine whether fecal microbiota transplant using Penn Microbiome Therapy products helps standard therapy to treat severe Clostridium difficile infection (C diff).

Severe Clostridium Difficile InfectionSevere-Complicated/Fulminant Clostridium Difficile Infection

University of Pennsylvania15 participantsStarted Jan 2020

Philadelphia, Pennsylvania, United States

TERMINATEDPhase 3< 1 mile

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

NCT05039359

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy and safety of FlecIH-103 (flecainide acetate inhalation solution) compared with placebo in patients with recent-onset, symptomatic newly diagnosed or paroxysmal AF. Approximately 400 patients are expected to be enrolled in this study. Patients will be randomized 3:1 to receive FlecIH-103 at a total dose of up to 120 mg estimated total lung dose (eTLD) (n=300) or placebo inhalation solution (n=100). Randomization will be stratified by geographic region (US and ex-US) and duration of symptoms of the current AF episode (≥1 hour to ≤24 hours and \>24 hours to ≤48 hours).

Paroxysmal Atrial Fibrillation

InCarda Therapeutics, Inc.54 participantsStarted Apr 2022

Davis, California, United States • Long Beach, California, United States • Bridgeport, Connecticut, United States +37 more locations

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

Find Trials by Condition in Philadelphia

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma

Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent Osteosarcoma

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

The Chocolate Touch Study

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Vtama in Psoriasis Patients Being Treated With Biologics.

Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout

A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer

A Study to Investigate Atezolizumab and Chemotherapy Compared With Placebo and Chemotherapy in the Neoadjuvant Setting in Participants With Early Stage Triple Negative Breast Cancer

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma

Developmental Impact of NICU Exposures (DINE)

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System

Study of the ConforMIS iDuo(R) G2